Loading
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (2 ops.)
Latest filing published 16 Mar 2018 for Neurotrope, Inc., €1,082.
Filing timeline
BuySaleJames Gottlieb
Insider track record
Disclosed buys
3
Disclosed sells
2
Signal history
Closed purchases
Market purchases
3
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
James Gottlieb: trading record in brief
This profile gathers the share dealings of James Gottlieb in Neurotrope, Inc. In total, 5 filings cover trades dated from 23 November 2015 to 15 March 2018.
Market trades split into 3 purchases (€5,543) and 2 sales (€2,136). Purchases outweigh sales by €3,406. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2018 alone, the filings show no purchases and 2 sales.
In size, the median ticket on the buying side is €2,661.
Most recently, on 16 March 2018, the filings show an open-market sale worth €1,082 in Neurotrope, Inc. The latest purchase dates back some time: it was published 3,986 days ago, on 24 November 2015. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to James Gottlieb
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
157 shares@ US$8.5350.7% of flowCommon StockSEC:0001144204-18-015273:0
157 shares@ US$8.3149.3% of flowCommon StockSEC:0001144204-18-015273:1
5,000 shares@ US$0.59Common StockSEC:0001144204-15-067759:0
Canonical exit: 21 Feb 2016 (T+90)
4,800 shares@ US$0.59Common StockSEC:0001144204-15-067759:1
Canonical exit: 21 Feb 2016 (T+90)
200 shares@ US$0.58Common StockSEC:0001144204-15-067759:2
Canonical exit: 21 Feb 2016 (T+90)
5 of 5 declarations
